Aroga partners with biotech and pharma teams to turn complex data into clear, compliant, ICH- and agency-aligned documents — from first-in-human through global submission.
Top 10 Medical Writing Provider — Life Sciences Review
Tell us about your program. We typically respond within one business day.
One partner for every regulatory, clinical, and scientific document your program needs.
Precision and strategy for every submission, aligned with FDA, EMA, and ICH expectations.
Comprehensive support across every stage of drug development, with accurate, consistent narratives.
DSURs, PSURs, Risk Management Plans (RMPs), Safety Updates
Technically sound, compliant documentation for manufacturing and product lifecycle needs.
Clear data interpretation that bridges raw study data and regulatory-ready narratives.
Scientific expertise plus publication strategy to communicate your research with impact.
Scientists and writers with the depth to engage your data, not just format it.
Documents built for internal review or agency submission from the first draft.
Consistent with ICH and regional FDA/EMA guidelines across every deliverable.
Flexible, dedicated, and committed to your milestones — including the tight ones.
Whether you’re preparing your first IND or finalizing a global NDA, our team is ready to help you bring your science to life — and your therapies to patients faster.
Regulatory medical writing turns scientific, clinical, nonclinical, safety, and manufacturing information into clear documents for health-authority review. Regulatory writers must accurately interpret data while following applicable guidelines, document structures, terminology, and submission requirements.
Aroga provides clinical, regulatory, safety, CMC, nonclinical, and publication writing. Deliverables include protocols, Clinical Study Reports, Investigator’s Brochures, IND and marketing-application content, safety reports, CTD summaries, manuscripts, abstracts, posters, and scientific presentations.
Aroga can support Clinical Study Reports, clinical study protocols, Investigator’s Brochures, Clinical Trial Applications, development plans, clinical summaries, and other documents used throughout clinical development. Writers work with source data and cross-functional contributors to produce scientifically accurate, internally consistent documents.
Yes. Aroga can support the writing, quality control, project management, publishing, and submission activities required for an Investigational New Drug application. The scope can be tailored to include individual IND documents or coordinated support across the submission package.
Yes. Aroga provides writing and submission support for New Drug Applications and Biologics License Applications. Services can include document authoring, CTD summaries, cross-document consistency review, quality control, publishing, validation, timeline management, and electronic submission support.
Yes. Aroga’s regulatory writers can help teams develop clear, scientifically supported responses to health-authority questions. Support may include organizing source information, coordinating subject-matter-expert input, drafting responses, resolving comments, and preparing final content for submission.
Aroga supports safety documents such as Development Safety Update Reports, Periodic Safety Update Reports, Risk Management Plans, safety updates, and related safety assessments. Its writers focus on accurate data presentation, consistency across reporting periods, and alignment with applicable pharmacovigilance requirements.
Yes. Aroga prepares CMC summaries, technical reports, Investigational Medicinal Product Dossiers, and related regulatory content. CMC writers help organize complex manufacturing and product information into technically accurate, logically structured documents suitable for regulatory review.
Yes. Aroga supports nonclinical study reports, toxicology reports, nonclinical summaries and overviews, and nonclinical sections of Investigator’s Brochures and regulatory submissions. Its writers translate study findings and source data into clear, traceable regulatory narratives.
Aroga can assess the available materials, identify missing information, and coordinate with client subject-matter experts to resolve gaps. Early identification of missing inputs can reduce revision cycles and prevent document delays later in the submission process.
Yes. Aroga supports manuscripts, conference abstracts, scientific posters, presentations, and speaker materials. Its publication writers combine scientific expertise with publication planning to communicate study findings accurately and effectively.
Yes. Journal selection can be incorporated into manuscript-development support. The team can evaluate the intended audience, scientific scope, article type, journal requirements, and publication objectives before preparing the manuscript for submission.
Yes. Aroga can support author coordination, review cycles, comment reconciliation, and preparation of the final manuscript. This helps maintain an organized process while ensuring that contributor feedback is appropriately addressed and documented.
Aroga prepares scientific communications with attention to applicable publication, journal, and authorship standards. Requirements are evaluated for each deliverable and target publication so the finished material is accurate, consistent, and appropriately prepared for submission.
Have another question? See all Aroga Biosciences FAQs →
